Phase II Study of Alternating Sunitinib and Temsirolimus
Clinical trial NCT01517243 · COMPLETED
Trial details
- NCT number
- NCT01517243
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-22
- Primary completion
- 2018-08-20
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.